KLRS·482929106·US·equity·Healthcare - Biotechnology-Activist
KLRS (KALARIS THERAPEUTICS INC) is held by 28 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($7.5M), Alyeska Investment Group, L.P. ($3.3M), RAYMOND JAMES FINANCIAL INC ($685,978). Net institutional sentiment: Mixed.
See how KLRS's score breaks down across 4 SEC sources
Showing 1-20 of 33
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer